[1]
2024. Should molnupiravir be used for covid-19 outpatient management in individuals at high risk for disease severity? A systematic review and meta-analysis of randomized controlled trials. Brazilian Journal of Pharmaceutical Sciences. 60, (nov. 2024). DOI:https://doi.org/10.1590/.